Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Starfish shell-mimicking crystals could advance 3-D printing pills

By Drug Discovery Trends Editor | October 21, 2014

Univ.  of Michigan engineering professors have made rounded crystals with no facets, a structure occasionally found in nature but difficult to produce in a laboratory. Image: Max Shtein In a design that mimics a hard-to-duplicate texture of starfish shells, Univ. of Michigan engineers have made rounded crystals that have no facets.

“We call them nanolobes. They look like little hot air balloons that are rising from the surface,” said Olga Shalev, a doctoral student in materials science and engineering who worked on the project.

Both the nanolobes’ shape and the way they’re made have promising applications, the researchers say. The geometry could potentially be useful to guide light in advanced LEDs, solar cells and non-reflective surfaces.

A layer might help a material repel water or dirt. And the process used to manufacture them—organic vapor jet printing—might lend itself to 3-D printing medications that absorb better into the body and make personalized dosing possible.

The nanoscale shapes are made out of boron subphthalocyanine chloride, a material often used in organic solar cells. It’s in a family of small molecular compounds that tend to make either flat films or faceted crystals with sharp edges, says Max Shtein, U-M associate professor of materials science and engineering, macromolecular science and engineering, chemical engineering, and art and design.

“In my years of working with these kinds of materials, I’ve never seen shapes that looked like these. They’re reminiscent of what you get from biological processes,” Shtein said. “Nature can sometimes produce crystals that are smooth, but engineers haven’t been able to do it reliably.”

Echinoderm sea creatures such as brittle stars have ordered rounded structures on their bodies that work as lenses to gather light into their rudimentary eyes. But in a laboratory, crystals composed of the same minerals tend either to be faceted with flat faces and sharp angles, or smooth, but lacking molecular order.

The U-M researchers made the curved crystals by accident several years ago. They’ve since traced their steps and figured out how to do it on purpose.

In 2010, Shaurjo Biswas, then a doctoral student at U-M, was making solar cells with the organic vapor jet printer. He was recalibrating the machine after switching between materials. Part of the recalibration process involves taking a close look at the fresh layers of material, of films, printed on a plate.

Biswas x-rayed several films of different thicknesses to observe the crystal structure. He noticed that the boron subphthalocyanine chloride, which typically does not form ordered shapes, started to do so once the film got thicker than 600 nm. He made some thicker films to see what would happen.

“At first, we wondered if our apparatus was functioning properly,” Shtein said.

At 800 nm thick, the repeating nanolobe pattern emerged every time.

For a long while, the blobs were lab curiosities. Researchers were focused on other things. Then doctoral student Shalev got involved. She was fascinated by the structures and wanted to understand the reason for the phenomenon. She repeated the experiments in a modified apparatus that gave more control over the conditions to vary them systematically.

Shalev collaborated with physics professor Roy Clarke to gain a better understanding of the crystallization, and mechanical engineering professor Wei Lu to simulate the evolution of the surface. She’s first author of a paper on the findings published in Nature Communications.

“As far as we know, no other technology can do this,” Shalev said.

The organic vapor jet printing process the researchers use is a technique Shtein helped to develop when he was in graduate school. He describes it as spray painting, but with a gas rather than with a liquid. It’s cheaper and easier to do for certain applications than competing approaches that involve stencils or can only be done in a vacuum, Shtein says. He’s especially hopeful about the prospects for this technique to advance emerging 3-D-printed pharmaceutical concepts.

For example, Shtein and Shalev believe this method offers a precise way to control the size and shape of the medicine particles, for easier absorption into the body. It could also allow drugs to be attached directly to other materials and it doesn’t require solvents that might introduce impurities.

Source: Univ. of Michigan


Filed Under: Drug Discovery

 

Related Articles Read More >

Red blood cells macro over red eritrosit background. Concept of blood cells count, medicine and healthcare. 3d rendering mock up
Platelet-inspired nanoparticle delivers drugs directly where they are needed
Lilly’s triple agonist delivers up to 71.2 lbs of weight loss in Phase 3 trial
China’s biopharma sector enters ‘innovation 2.0’ era
The FDA’s AI ambitions depend on better data practices
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE